Graveoline Analogs Exhibiting Selective Acetylcholinesterase Inhibitory Activity as Potential Lead Compounds for the Treatment of Alzheimer’s Disease

Molecules - Switzerland
doi 10.3390/molecules21020132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Novel Multipotent Tacrine-Dihydropyridine Hybrids With Improved Acetylcholinesterase Inhibitory and Neuroprotective Activities as Potential Drugs for the Treatment of Alzheimers Disease

English

Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer’s Disease

Marine Drugs
Drug Discovery
2019English

Analogs of the Lignan Pinoresinol as Novel Lead Compounds for P-Glycoprotein (P-Gp) Inhibitors

ACS Medicinal Chemistry Letters
Organic ChemistryBiochemistryDrug Discovery
2018English

PPARγ Agonists as Therapeutics for the Treatment of Alzheimer’s Disease

Neurotherapeutics
NeurologyPharmacology
2008English

Antioxidative / Acetylcholinesterase Inhibitory Activity of Some Asteraceae Plants

Natural Product Communications
PharmacologyComplementaryPlant ScienceAlternative MedicineMedicineDrug Discovery
2013English

Filipin Levels as Potential Predictors of Alzheimer’s Disease Risk

Advances in Alzheimer's Disease
2014English

Screening of Traditional European Herbal Medicines for Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activity

Acta Pharmaceutica
MedicinePharmacologyPharmaceutical Science
2010English

Aporphine Alkaloids From Piper Erecticaule and Acetylcholinesterase Inhibitory Activity

Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas
Drug DiscoveryAlternative MedicinePlant SciencePharmacologyComplementary
2019English

Lead Compounds From Cucurbitaceae for the Treatment of Cancer

2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy